← Browse by Condition
Medical Condition
pancreas cancer
Total Trials
17
Recruiting Now
17
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT06229340 Phase 2
Recruiting
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Enrollment
20 pts
Location
Russia
Sponsor
N.N. Petrov National Medical R...
NCT06010862 Phase 1
Recruiting
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
Enrollment
36 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT07132541 Phase 1
Recruiting
Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)
Enrollment
30 pts
Location
Egypt
Sponsor
Minia University
NCT02775461
Recruiting
Pancreas Registry and High Risk Registry
Enrollment
1,368 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
NCT04571294
Recruiting
Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy
Enrollment
180 pts
Location
Italy
Sponsor
Humanitas Hospital, Italy
NCT07034339
Recruiting
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
Enrollment
1,500 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT03484299 Phase 1
Recruiting
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Enrollment
20 pts
Location
United States
Sponsor
University of Louisville
NCT06572813 Phase 1, Phase 2
Recruiting
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
Enrollment
63 pts
Location
China
Sponsor
Zhejiang University
NCT07022015
Recruiting
Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy
Enrollment
100 pts
Location
Egypt
Sponsor
Minia University
NCT05517811
Recruiting
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Enrollment
400 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06158139 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Enrollment
27 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
NCT05170802
Recruiting
Pancreatic Cancer & Surgical Resection
Enrollment
30 pts
Location
United States
Sponsor
Methodist Health System
NCT07045571
Recruiting
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
Enrollment
1,000 pts
Location
China
Sponsor
Yingbin Liu, MD, PhD, FACS
NCT05155878
Recruiting
Prognostic Factors in Periampullary Tumors and Cysts
Enrollment
500 pts
Location
Sweden
Sponsor
Umeå University
NCT07081360 Phase 3
Recruiting
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Enrollment
262 pts
Location
Egypt
Sponsor
Minia University
NCT05679674
Recruiting
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
Enrollment
48 pts
Location
United States
Sponsor
Baptist Health South Florida